Saigeetha Sundaramurthy, MD
Rheumatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sundaramurthy’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A67156 · Current
Licensed to practise in California · since 1998 · expires 2028-09-30 · University of Madras, Madras Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$178,564
Medicare paid this office $178,564 for 313 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 32 | $66,486 | None |
| Return visit (30+ min) | 219 | $51,563 | $112 |
| Short return visit (20+ min) | 108 | $10,792 | $84 |
| New patient visit (45+ min) | 70 | $10,247 | $146 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 247 | $6,761 | $15 |
See all 10 services
| Injection, denosumab, 1 mg | 32 | $66,486 | None |
| Return visit (30+ min) | 219 | $51,563 | $112 |
| Short return visit (20+ min) | 108 | $10,792 | $84 |
| New patient visit (45+ min) | 70 | $10,247 | $146 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 247 | $6,761 | $15 |
| Long return visit (40+ min) | 17 | $3,545 | $154 |
| New patient visit (60+ min) | 13 | $2,522 | $194 |
| Injection of drug or substance under skin or into muscle | 61 | $1,870 | $13 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,546 | $74 |
| Injection, methylprednisolone acetate, 1 mg | 25 | $171 | None |
Who their Medicare patients are
313 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 15% · Women 82% · Also on Medicaid 13% · Health risk score 1.22. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 29% · Coronary heart disease 22% · Chronic kidney disease 22% · Depression 18% · Atrial fibrillation 15% · Heart failure 14% · COPD 14% · Cancer 11% · Stroke 9% · Dementia 7%.
The office billed $678,533, Medicare allowed $235,220 and paid $178,564; for 8,617 services of 29 kinds; $87,324 of it was for drugs given in the office and $91,240 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 313 | 8,617 | 75 | 1.22 | $678,533 | $178,564 |
| 2023 | 307 | 3,790 | 76 | 1.12 | $523,397 | $131,719 |
| 2022 | 282 | 2,591 | 76 | 1.07 | $415,327 | $103,370 |
| 2021 | 273 | 2,771 | 75 | 1.24 | $404,519 | $110,801 |
| 2020 | 260 | 3,651 | 74 | 1.31 | $604,451 | $160,797 |
| 2019 | 259 | 1,989 | 75 | 1.32 | $354,002 | $86,625 |
| 2018 | 253 | 1,423 | 74 | 1.45 | $297,163 | $71,161 |
| 2017 | 242 | 1,711 | 75 | 1.50 | $263,891 | $74,571 |
| 2016 | 241 | 1,312 | 74 | 1.53 | $230,063 | $62,706 |
| 2015 | 224 | 900 | 75 | 1.39 | $169,721 | $55,002 |
| 2014 | 124 | 916 | 73 | 1.17 | $114,738 | $36,197 |
| 2013 | 105 | 457 | 72 | 1.20 | $62,168 | $26,965 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 210 | $47,605 | $112 |
| Injection, denosumab, 1 mg | 26 | $43,957 | None |
| New patient visit (45+ min) | 67 | $9,689 | $145 |
| Short return visit (20+ min) | 100 | $9,409 | $74 |
| Long return visit (40+ min) | 29 | $7,442 | $165 |
| New patient visit (60+ min) | 17 | $3,229 | $190 |
| Injection of drug or substance under skin or into muscle | 62 | $1,993 | $13 |
| Aspiration and/or injection of fluid from large joint | 21 | $1,883 | $65 |
| Injection, methylprednisolone acetate, 40 mg | 14 | $222 | None |
2022: 10 services
| Return visit (30+ min) | 195 | $42,477 | $109 |
| Injection, denosumab, 1 mg | 24 | $30,971 | None |
| Short return visit (20+ min) | 98 | $9,514 | $81 |
| New patient visit (45+ min) | 55 | $7,186 | $131 |
| Long return visit (40+ min) | 18 | $4,854 | $173 |
| New patient visit (60+ min) | 13 | $2,301 | $177 |
| Injection of drug or substance under skin or into muscle | 41 | $1,160 | $13 |
| Influenza vaccine split virus, preservative free | 11 | $751 | $68 |
| Administration of influenza virus vaccine | 12 | $456 | $38 |
| Injection, methylprednisolone acetate, 80 mg | 11 | $105 | None |
2021: 10 services
| Return visit (30+ min) | 187 | $46,100 | $116 |
| Injection, denosumab, 1 mg | 18 | $30,796 | None |
| New patient visit (45+ min) | 70 | $10,755 | $154 |
| Short return visit (20+ min) | 81 | $7,060 | $74 |
| Long return visit (40+ min) | 19 | $4,235 | $176 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $2,794 | $74 |
| Injection of drug or substance under skin or into muscle | 53 | $1,620 | $14 |
| Aspiration and/or injection of fluid from large joint | 20 | $1,468 | $56 |
| Injection, methylprednisolone acetate, 80 mg | 31 | $350 | None |
| Administration of influenza virus vaccine | 12 | $262 | $22 |
2020: 11 services
| Return visit (30+ min) | 134 | $22,863 | $93 |
| Injection, denosumab, 1 mg | 12 | $16,743 | None |
| New patient visit (45+ min) | 63 | $9,270 | $147 |
| Short return visit (20+ min) | 102 | $7,789 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 60 | $5,050 | $68 |
| Telephone medical discussion with physician, 21-30 minutes | 34 | $3,486 | $100 |
| Aspiration and/or injection of fluid from large joint | 21 | $1,588 | $57 |
| Injection of drug or substance under skin or into muscle | 48 | $1,266 | $12 |
| Injection, methylprednisolone acetate, 80 mg | 34 | $445 | None |
| Administration of influenza virus vaccine | 14 | $293 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $273 | $20 |
2019: 12 services
| Return visit (30+ min) | 176 | $36,160 | $89 |
| Short return visit (20+ min) | 133 | $11,650 | $67 |
| Injection, denosumab, 1 mg | 15 | $9,936 | None |
| New patient visit (45+ min) | 59 | $8,152 | $138 |
| Injection of drug or substance under skin or into muscle | 47 | $1,960 | $15 |
| Aspiration and/or injection of fluid from large joint | 23 | $1,606 | $52 |
| New patient visit (30+ min) | 14 | $1,075 | $77 |
| Injection, methylprednisolone acetate, 80 mg | 23 | $393 | None |
| Administration of influenza virus vaccine | 15 | $308 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 16 | $298 | $19 |
| Injection, methylprednisolone acetate, 40 mg | 28 | $143 | None |
| Injection, methylprednisolone acetate, 20 mg | 30 | $127 | None |
2018: 13 services
| Return visit (30+ min) | 190 | $41,688 | $89 |
| New patient visit (45+ min) | 64 | $9,327 | $146 |
| Injection, denosumab, 1 mg | 11 | $6,068 | None |
| Short return visit (20+ min) | 57 | $4,035 | $55 |
| Injection of drug or substance under skin or into muscle | 58 | $2,926 | $19 |
| Long return visit (40+ min) | 12 | $1,872 | $125 |
| Aspiration and/or injection of fluid from large joint | 20 | $1,388 | $60 |
| Injection into tendon or ligament | 13 | $801 | $50 |
| Aspiration and/or injection of fluid from small joint | 13 | $618 | $44 |
| Administration of influenza virus vaccine | 15 | $412 | $26 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 16 | $298 | $18 |
| Injection, methylprednisolone acetate, 40 mg | 36 | $271 | None |
| Injection, methylprednisolone acetate, 20 mg | 40 | $186 | None |
2017: 11 services
| Return visit (30+ min) | 196 | $42,103 | $85 |
| New patient visit (45+ min) | 68 | $8,986 | $132 |
| Short return visit (20+ min) | 55 | $3,475 | $54 |
| Injection of drug or substance under skin or into muscle | 54 | $3,302 | $22 |
| Long return visit (40+ min) | 13 | $2,222 | $123 |
| Aspiration and/or injection of fluid from large joint | 24 | $1,832 | $56 |
| Aspiration and/or injection of fluid from small joint | 17 | $887 | $44 |
| Administration of influenza virus vaccine | 14 | $452 | $32 |
| Injection, methylprednisolone acetate, 40 mg | 52 | $300 | None |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 15 | $280 | $19 |
| Injection, methylprednisolone acetate, 20 mg | 49 | $253 | None |
2016: 12 services
| Return visit (30+ min) | 188 | $39,731 | $85 |
| New patient visit (45+ min) | 56 | $7,890 | $141 |
| Short return visit (20+ min) | 38 | $3,097 | $58 |
| Long return visit (40+ min) | 16 | $2,325 | $129 |
| Aspiration and/or injection of fluid from large joint | 23 | $1,663 | $57 |
| Injection of drug or substance under skin or into muscle | 36 | $1,460 | $22 |
| Administration of influenza virus vaccine | 26 | $824 | $32 |
| Aspiration and/or injection of fluid from small joint | 14 | $717 | $38 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 23 | $426 | $19 |
| Injection, methylprednisolone acetate, 40 mg | 49 | $297 | None |
| Injection, methylprednisolone acetate, 20 mg | 39 | $175 | None |
| Injection, methylprednisolone acetate, 80 mg | 11 | $90 | None |
2015: 11 services
| Return visit (30+ min) | 171 | $31,280 | $101 |
| New patient visit (45+ min) | 64 | $10,081 | $158 |
| Short return visit (20+ min) | 45 | $3,776 | $67 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,634 | $65 |
| Injection of drug or substance under skin or into muscle | 27 | $932 | $26 |
| Administration of influenza virus vaccine | 28 | $890 | $32 |
| Aspiration and/or injection of fluid from small joint | 15 | $863 | $51 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 17 | $303 | $18 |
| Injection, methylprednisolone acetate, 40 mg | 29 | $162 | None |
| Injection, methylprednisolone acetate, 20 mg | 33 | $96 | None |
| Injection, methylprednisolone acetate, 80 mg | 11 | $85 | None |
2014: 9 services
| Return visit (30+ min) | 93 | $20,127 | $92 |
| New patient visit (45+ min) | 31 | $4,312 | $139 |
| Short return visit (20+ min) | 37 | $2,464 | $55 |
| Aspiration and/or injection of fluid from large joint | 11 | $1,084 | $64 |
| Administration of influenza virus vaccine | 14 | $436 | $31 |
| Injection of drug or substance under skin or into muscle | 13 | $349 | $23 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 12 | $181 | $15 |
| Injection, methylprednisolone acetate, 20 mg | 22 | $74 | None |
| Injection, methylprednisolone acetate, 40 mg | 16 | $53 | None |
2013: 6 services
| Return visit (30+ min) | 80 | $16,922 | $92 |
| New patient visit (45+ min) | 38 | $5,374 | $141 |
| Short return visit (20+ min) | 14 | $870 | $54 |
| Administration of influenza virus vaccine | 13 | $418 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 13 | $191 | $15 |
| Injection, methylprednisolone acetate, 40 mg | 21 | $72 | None |
Drugs they prescribed that Part D paid
$1,556,894
Pharmacies billed $1,556,894 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (17 of 1,896) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
1,465 generic and 409 brand-name prescriptions · $1,556,894 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 23 | $264,745 | $11,511 |
| Prolia | 128 | $220,980 | $1,726 |
| Tymlos | 60 | $194,972 | $3,250 |
| Enbrel | 26 | $183,336 | $7,051 |
| Humira | 23 | $159,436 | $6,932 |
See all 33 drugs
| Enbrel Sureclick | 23 | $264,745 | $11,511 |
| Prolia | 128 | $220,980 | $1,726 |
| Tymlos | 60 | $194,972 | $3,250 |
| Enbrel | 26 | $183,336 | $7,051 |
| Humira | 23 | $159,436 | $6,932 |
| Humira(Cf) | 21 | $152,865 | $7,279 |
| Otezla | 13 | $59,591 | $4,584 |
| Hydroxychloroquine Sulfate | 147 | $6,762 | $46 |
| Methotrexate | 183 | $4,435 | $24 |
| Celecoxib | 167 | $4,338 | $26 |
| Diclofenac | 106 | $3,536 | $33 |
| Gabapentin | 105 | $2,326 | $22 |
| Sulfasalazine Dr | 44 | $2,067 | $47 |
| Alendronate | 155 | $1,568 | $10 |
| Risedronate | 11 | $1,477 | $134 |
| Mycophenolate Mofetil | 25 | $1,301 | $52 |
| Colchicine | 26 | $1,284 | $49 |
| Leflunomide | 22 | $1,284 | $58 |
| Prednisone | 145 | $978 | $7 |
| Leucovorin | 38 | $866 | $23 |
| Azathioprine | 12 | $650 | $54 |
| Pilocarpine | 14 | $646 | $46 |
| Sulfasalazine | 21 | $596 | $28 |
| Folic Acid | 59 | $559 | $9 |
| Pregabalin | 22 | $490 | $22 |
| Allopurinol | 45 | $390 | $9 |
| Duloxetine | 12 | $360 | $30 |
| Methylprednisolone | 16 | $292 | $18 |
| Meloxicam | 38 | $189 | $5 |
| Tizanidine | 15 | $187 | $12 |
| Hydrochlorothiazide | 26 | $148 | $6 |
| Amlodipine Besylate | 15 | $76 | $5 |
| Tramadol | 17 | $45 | $3 |
Year by year
| 2024 | 1,896 | 377 | 1% (17) | 22% | $1,556,894 |
| 2023 | 2,224 | 390 | 1% (16) | 22% | $1,761,834 |
| 2022 | 2,453 | 388 | 2% (37) | 19% | $1,579,141 |
| 2021 | 2,901 | 419 | 2% (54) | 18% | $1,648,284 |
| 2020 | 2,589 | 387 | 2% (40) | 17% | $1,237,829 |
| 2019 | 2,511 | 382 | 2% (50) | 18% | $1,118,103 |
| 2018 | 2,532 | 384 | 2% (46) | 19% | $1,060,730 |
| 2017 | 2,888 | 405 | 2% (62) | 19% | $885,844 |
| 2016 | 3,199 | 409 | 2% (72) | 23% | $755,307 |
| 2015 | 2,094 | 351 | 3% (67) | 28% | $505,615 |
| 2014 | 1,461 | 204 | 3% (50) | 28% | $229,454 |
| 2013 | 1,453 | 187 | 4% (62) | 31% | $243,312 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Humira(Cf) | 34 | $267,803 | $7,877 |
| Enbrel Sureclick | 22 | $260,958 | $11,862 |
| Prolia | 137 | $235,283 | $1,717 |
| Enbrel | 29 | $229,399 | $7,910 |
| Humira | 22 | $161,583 | $7,345 |
| Tymlos | 55 | $157,449 | $2,863 |
| Forteo | 14 | $63,291 | $4,521 |
| Benlysta | 11 | $59,251 | $5,386 |
| Otezla | 13 | $58,629 | $4,510 |
| Hydroxychloroquine Sulfate | 163 | $14,066 | $86 |
| Methotrexate | 251 | $9,784 | $39 |
| Diclofenac | 202 | $7,549 | $37 |
| Leflunomide | 50 | $7,045 | $141 |
| Celecoxib | 127 | $6,763 | $53 |
| Lidocaine | 11 | $4,084 | $371 |
| Sulfasalazine Dr | 68 | $3,093 | $45 |
| Cevimeline | 16 | $3,031 | $189 |
| Colchicine | 29 | $2,695 | $93 |
| Risedronate | 16 | $2,459 | $154 |
| Alendronate | 155 | $2,423 | $16 |
| Gabapentin | 105 | $2,282 | $22 |
| Pilocarpine | 16 | $2,111 | $132 |
| Prednisone | 178 | $1,848 | $10 |
| Pregabalin | 38 | $1,631 | $43 |
| Mycophenolate Mofetil | 11 | $1,414 | $129 |
| Leucovorin | 55 | $1,198 | $22 |
| Methylprednisolone | 18 | $1,141 | $63 |
| Duloxetine | 14 | $1,129 | $81 |
| Sulfasalazine | 26 | $841 | $32 |
| Allopurinol | 51 | $559 | $11 |
| Tizanidine | 14 | $294 | $21 |
| Omeprazole | 13 | $247 | $19 |
| Folic Acid | 47 | $234 | $5 |
| Amlodipine Besylate | 18 | $213 | $12 |
| Meloxicam | 32 | $175 | $5 |
| Tramadol | 16 | $145 | $9 |
| Insulin | 11 | $116 | $11 |
| Hydrochlorothiazide | 31 | $80 | $3 |
2022: 35 drugs
| Humira(Cf) | 33 | $251,023 | $7,607 |
| Enbrel Sureclick | 25 | $240,364 | $9,615 |
| Enbrel | 29 | $202,487 | $6,982 |
| Prolia | 119 | $180,791 | $1,519 |
| Forteo | 36 | $153,055 | $4,252 |
| Tymlos | 48 | $120,035 | $2,501 |
| Humira | 13 | $88,421 | $6,802 |
| Otezla | 12 | $55,872 | $4,656 |
| Hydroxychloroquine Sulfate | 165 | $13,534 | $82 |
| Methotrexate | 275 | $9,857 | $36 |
| Diclofenac | 213 | $7,653 | $36 |
| Celecoxib | 151 | $7,139 | $47 |
| Leflunomide | 52 | $6,170 | $119 |
| Sulfasalazine Dr | 78 | $3,732 | $48 |
| Risedronate | 12 | $3,306 | $275 |
| Prednisone | 237 | $2,767 | $12 |
| Sulfasalazine | 62 | $2,757 | $44 |
| Alendronate | 193 | $2,490 | $13 |
| Pilocarpine | 13 | $2,298 | $177 |
| Gabapentin | 73 | $1,539 | $21 |
| Pregabalin | 32 | $1,501 | $47 |
| Leucovorin | 69 | $1,456 | $21 |
| Methylprednisolone | 25 | $1,441 | $58 |
| Mycophenolate Mofetil | 13 | $1,247 | $96 |
| Colchicine | 12 | $1,035 | $86 |
| Duloxetine | 19 | $612 | $32 |
| Methotrexate | 33 | $571 | $17 |
| Allopurinol | 26 | $519 | $20 |
| Tizanidine | 19 | $474 | $25 |
| Folic Acid | 50 | $334 | $7 |
| Meloxicam | 60 | $325 | $5 |
| Tramadol | 36 | $308 | $9 |
| Omeprazole | 22 | $285 | $13 |
| Amlodipine Besylate | 17 | $161 | $9 |
| Hydrochlorothiazide | 29 | $124 | $4 |
2021: 41 drugs
| Humira(Cf) | 33 | $220,764 | $6,690 |
| Enbrel | 35 | $220,480 | $6,299 |
| Enbrel Sureclick | 19 | $186,607 | $9,821 |
| Forteo | 47 | $185,032 | $3,937 |
| Prolia | 115 | $160,116 | $1,392 |
| Humira | 18 | $113,810 | $6,323 |
| Tymlos | 45 | $100,819 | $2,240 |
| Xeljanz | 15 | $87,650 | $5,843 |
| Otezla | 11 | $46,786 | $4,253 |
| Diclofenac | 333 | $17,528 | $53 |
| Hydroxychloroquine Sulfate | 213 | $16,301 | $77 |
| Methotrexate | 414 | $12,621 | $30 |
| Leflunomide | 54 | $8,111 | $150 |
| Celecoxib | 91 | $5,599 | $62 |
| Cevimeline | 15 | $4,735 | $316 |
| Prednisone | 316 | $4,597 | $15 |
| Sulfasalazine | 87 | $4,105 | $47 |
| Risedronate | 12 | $3,688 | $307 |
| Lidocaine | 12 | $3,442 | $287 |
| Pilocarpine | 16 | $3,189 | $199 |
| Sulfasalazine Dr | 55 | $3,076 | $56 |
| Pregabalin | 42 | $2,590 | $62 |
| Alendronate | 188 | $2,432 | $13 |
| Methylprednisolone | 25 | $1,283 | $51 |
| Leucovorin | 59 | $1,280 | $22 |
| Azathioprine | 16 | $1,234 | $77 |
| Gabapentin | 74 | $1,003 | $14 |
| Methotrexate | 57 | $829 | $15 |
| Tizanidine | 32 | $695 | $22 |
| Allopurinol | 34 | $551 | $16 |
| Duloxetine | 19 | $411 | $22 |
| Meloxicam | 70 | $354 | $5 |
| Tramadol | 47 | $327 | $7 |
| Baclofen | 17 | $271 | $16 |
| Folic Acid | 36 | $238 | $7 |
| Amlodipine Besylate | 26 | $190 | $7 |
| Ibuprofen | 17 | $157 | $9 |
| Insulin | 12 | $112 | $9 |
| Pantoprazole | 17 | $111 | $7 |
| Hydrochlorothiazide | 25 | $85 | $3 |
| Vitamin D2 | 13 | $75 | $6 |
2020: 34 drugs
| Enbrel Sureclick | 17 | $172,583 | $10,152 |
| Enbrel | 29 | $171,431 | $5,911 |
| Forteo | 37 | $134,147 | $3,626 |
| Prolia | 87 | $112,163 | $1,289 |
| Xeljanz | 23 | $109,387 | $4,756 |
| Humira | 13 | $86,862 | $6,682 |
| Hydroxychloroquine Sulfate | 198 | $22,127 | $112 |
| Diclofenac | 319 | $21,630 | $68 |
| Methotrexate | 367 | $11,400 | $31 |
| Celecoxib | 137 | $8,021 | $59 |
| Leflunomide | 43 | $5,434 | $126 |
| Sulfasalazine | 91 | $4,353 | $48 |
| Sulfasalazine Dr | 46 | $3,819 | $83 |
| Prednisone | 290 | $3,475 | $12 |
| Pilocarpine | 18 | $3,270 | $182 |
| Cevimeline | 13 | $3,094 | $238 |
| Lidocaine | 11 | $2,640 | $240 |
| Pregabalin | 39 | $1,953 | $50 |
| Gabapentin | 89 | $1,780 | $20 |
| Alendronate | 134 | $1,667 | $12 |
| Leucovorin | 61 | $1,449 | $24 |
| Duloxetine | 23 | $1,015 | $44 |
| Methotrexate | 65 | $915 | $14 |
| Azathioprine | 18 | $653 | $36 |
| Allopurinol | 51 | $499 | $10 |
| Insulin | 19 | $376 | $20 |
| Tizanidine | 34 | $360 | $11 |
| Meloxicam | 48 | $331 | $7 |
| Tramadol | 33 | $294 | $9 |
| Amlodipine Besylate | 17 | $147 | $9 |
| Ibuprofen | 14 | $128 | $9 |
| Pantoprazole | 25 | $104 | $4 |
| Hydrochlorothiazide | 20 | $77 | $4 |
| Folic Acid | 13 | $58 | $4 |
2019: 32 drugs
| Enbrel | 20 | $202,256 | $10,113 |
| Enbrel Sureclick | 26 | $175,814 | $6,762 |
| Humira | 16 | $128,754 | $8,047 |
| Prolia | 77 | $93,644 | $1,216 |
| Humira | 11 | $60,475 | $5,498 |
| Xeljanz | 13 | $57,392 | $4,415 |
| Hydroxychloroquine Sulfate | 195 | $24,768 | $127 |
| Diclofenac | 218 | $22,578 | $104 |
| Methotrexate | 337 | $11,126 | $33 |
| Leflunomide | 64 | $8,873 | $139 |
| Celecoxib | 91 | $5,868 | $64 |
| Sulfasalazine Dr | 69 | $5,821 | $84 |
| Sulfasalazine | 122 | $4,213 | $35 |
| Prednisone | 317 | $3,929 | $12 |
| Gabapentin | 133 | $3,639 | $27 |
| Voltaren | 17 | $2,791 | $164 |
| Alendronate | 144 | $1,847 | $13 |
| Leucovorin | 67 | $1,740 | $26 |
| Duloxetine | 19 | $1,227 | $65 |
| Meloxicam | 76 | $1,023 | $13 |
| Tramadol | 32 | $932 | $29 |
| Methotrexate | 82 | $876 | $11 |
| Allopurinol | 45 | $775 | $17 |
| Pregabalin | 11 | $765 | $70 |
| Tizanidine | 29 | $560 | $19 |
| Mycophenolate Mofetil | 17 | $521 | $31 |
| Azathioprine | 23 | $286 | $12 |
| Trazodone | 13 | $218 | $17 |
| Insulin | 27 | $161 | $6 |
| Pantoprazole | 19 | $155 | $8 |
| Amlodipine Besylate | 25 | $133 | $5 |
| Tramadol Hcl-Acetaminophen | 14 | $124 | $9 |
2018: 32 drugs
| Enbrel Sureclick | 23 | $187,033 | $8,132 |
| Enbrel | 21 | $181,401 | $8,638 |
| Humira | 20 | $101,119 | $5,056 |
| Prolia | 84 | $98,618 | $1,174 |
| Otezla | 15 | $78,233 | $5,216 |
| Humira | 13 | $77,360 | $5,951 |
| Hydroxychloroquine Sulfate | 277 | $35,508 | $128 |
| Lyrica | 30 | $24,931 | $831 |
| Diclofenac | 185 | $20,168 | $109 |
| Leflunomide | 76 | $14,240 | $187 |
| Methotrexate | 306 | $13,557 | $44 |
| Celecoxib | 66 | $7,810 | $118 |
| Sulfasalazine Dr | 65 | $5,057 | $78 |
| Prednisone | 345 | $5,057 | $15 |
| Sulfasalazine | 103 | $3,800 | $37 |
| Voltaren | 23 | $3,337 | $145 |
| Pilocarpine | 19 | $3,321 | $175 |
| Gabapentin | 115 | $2,827 | $25 |
| Methylprednisolone | 17 | $1,541 | $91 |
| Duloxetine | 14 | $1,519 | $109 |
| Alendronate | 127 | $1,406 | $11 |
| Leucovorin | 56 | $1,331 | $24 |
| Methotrexate | 86 | $1,177 | $14 |
| Meloxicam | 93 | $1,053 | $11 |
| Allopurinol | 55 | $854 | $16 |
| Ranitidine | 13 | $755 | $58 |
| Tramadol | 35 | $661 | $19 |
| Tizanidine | 17 | $626 | $37 |
| Azathioprine | 17 | $403 | $24 |
| Ciprofloxacin | 14 | $118 | $8 |
| Amlodipine Besylate | 14 | $93 | $7 |
| Insulin | 27 | $75 | $3 |
2017: 34 drugs
| Enbrel Sureclick | 42 | $197,928 | $4,713 |
| Prolia | 86 | $94,319 | $1,097 |
| Humira | 17 | $94,289 | $5,546 |
| Enbrel | 18 | $90,628 | $5,035 |
| Humira | 11 | $62,359 | $5,669 |
| Hydroxychloroquine Sulfate | 311 | $47,020 | $151 |
| Leflunomide | 116 | $19,028 | $164 |
| Methotrexate | 330 | $17,339 | $53 |
| Lyrica | 18 | $14,616 | $812 |
| Diclofenac | 93 | $9,331 | $100 |
| Sulfasalazine Dr | 95 | $6,371 | $67 |
| Voltaren | 38 | $5,977 | $157 |
| Prednisone | 412 | $5,833 | $14 |
| Sulfasalazine | 126 | $4,410 | $35 |
| Celecoxib | 50 | $3,325 | $67 |
| Risedronate | 14 | $3,295 | $235 |
| Gabapentin | 174 | $2,913 | $17 |
| Pilocarpine | 13 | $2,373 | $183 |
| Alendronate | 185 | $1,559 | $8 |
| Methotrexate | 63 | $1,006 | $16 |
| Azathioprine | 18 | $839 | $47 |
| Leucovorin | 46 | $823 | $18 |
| Duloxetine | 19 | $681 | $36 |
| Meloxicam | 175 | $660 | $4 |
| Ranitidine | 16 | $587 | $37 |
| Allopurinol | 51 | $547 | $11 |
| Tramadol | 45 | $535 | $12 |
| Tizanidine | 15 | $321 | $21 |
| Amlodipine Besylate | 35 | $204 | $6 |
| Trazodone | 18 | $176 | $10 |
| Insulin | 22 | $168 | $8 |
| Hydrocodone-Acetaminophen | 13 | $134 | $10 |
| Isoniazid | 14 | $85 | $6 |
| Ciprofloxacin | 13 | $68 | $5 |
2016: 39 drugs
| Humira | 27 | $163,330 | $6,049 |
| Prolia | 84 | $85,276 | $1,015 |
| Enbrel | 19 | $76,483 | $4,025 |
| Humira | 19 | $73,808 | $3,885 |
| Hydroxychloroquine Sulfate | 441 | $64,047 | $145 |
| Orencia | 14 | $59,372 | $4,241 |
| Xeljanz | 11 | $35,964 | $3,269 |
| Otezla | 11 | $28,633 | $2,603 |
| Methotrexate | 411 | $22,657 | $55 |
| Leflunomide | 114 | $19,549 | $171 |
| Lyrica | 21 | $15,769 | $751 |
| Sulfasalazine | 195 | $6,494 | $33 |
| Prednisone | 414 | $6,273 | $15 |
| Sulfasalazine Dr | 82 | $5,963 | $73 |
| Risedronate | 24 | $4,608 | $192 |
| Voltaren | 33 | $4,261 | $129 |
| Diclofenac | 32 | $3,451 | $108 |
| Celecoxib | 40 | $3,380 | $85 |
| Gabapentin | 118 | $3,115 | $26 |
| Alendronate | 181 | $2,197 | $12 |
| Duloxetine | 44 | $2,135 | $49 |
| Leucovorin | 68 | $1,212 | $18 |
| Azathioprine | 14 | $1,170 | $84 |
| Methotrexate | 69 | $1,129 | $16 |
| Meloxicam | 187 | $1,029 | $6 |
| Allopurinol | 58 | $861 | $15 |
| Tizanidine | 18 | $782 | $43 |
| Etodolac Er | 11 | $603 | $55 |
| Pantoprazole | 25 | $601 | $24 |
| Hydrocodone-Acetaminophen | 15 | $453 | $30 |
| Insulin | 33 | $337 | $10 |
| Tramadol | 41 | $325 | $8 |
| Ranitidine | 15 | $302 | $20 |
| Potassium Chloride | 13 | $164 | $13 |
| Amlodipine Besylate | 45 | $164 | $4 |
| Omeprazole | 15 | $159 | $11 |
| Isoniazid | 23 | $121 | $5 |
| Ibuprofen | 13 | $100 | $8 |
| Ciprofloxacin | 12 | $100 | $8 |
2015: 30 drugs
| Humira | 21 | $108,773 | $5,180 |
| Enbrel | 18 | $59,126 | $3,285 |
| Hydroxychloroquine Sulfate | 320 | $54,270 | $170 |
| Prolia | 51 | $47,900 | $939 |
| Humira | 12 | $38,912 | $3,243 |
| Simponi | 11 | $38,627 | $3,512 |
| Methotrexate | 276 | $20,989 | $76 |
| Leflunomide | 75 | $8,294 | $111 |
| Voltaren | 53 | $6,735 | $127 |
| Lyrica | 12 | $6,333 | $528 |
| Sulfasalazine | 154 | $4,792 | $31 |
| Sulfasalazine Dr | 69 | $4,460 | $65 |
| Risedronate | 20 | $4,352 | $218 |
| Prednisone | 252 | $3,835 | $15 |
| Celecoxib | 22 | $1,989 | $90 |
| Gabapentin | 78 | $1,729 | $22 |
| Duloxetine | 16 | $1,699 | $106 |
| Leucovorin | 64 | $1,182 | $18 |
| Hydrocodone-Acetaminophen | 36 | $976 | $27 |
| Alendronate | 82 | $919 | $11 |
| Methylprednisolone | 11 | $889 | $81 |
| Methotrexate | 34 | $660 | $19 |
| Meloxicam | 66 | $514 | $8 |
| Allopurinol | 41 | $422 | $10 |
| Pantoprazole | 29 | $402 | $14 |
| Insulin | 26 | $383 | $15 |
| Indomethacin | 11 | $297 | $27 |
| Tramadol | 19 | $119 | $6 |
| Amlodipine Besylate | 29 | $117 | $4 |
| Isoniazid | 13 | $60 | $5 |
2014: 25 drugs
| Humira | 39 | $128,016 | $3,282 |
| Methotrexate | 248 | $21,089 | $85 |
| Hydroxychloroquine Sulfate | 220 | $7,464 | $34 |
| Voltaren | 60 | $6,747 | $112 |
| Celebrex | 18 | $4,365 | $242 |
| Actonel | 15 | $3,178 | $212 |
| Sulfasalazine | 96 | $2,947 | $31 |
| Sulfasalazine Dr | 46 | $2,337 | $51 |
| Prednisone | 143 | $2,017 | $14 |
| Methylprednisolone | 12 | $1,295 | $108 |
| Leflunomide | 45 | $1,217 | $27 |
| Sulfazine Ec | 21 | $1,131 | $54 |
| Hydrocodone-Acetaminophen | 16 | $1,071 | $67 |
| Leucovorin | 60 | $923 | $15 |
| Gabapentin | 46 | $780 | $17 |
| Methotrexate | 17 | $762 | $45 |
| Sulfazine | 15 | $738 | $49 |
| Alendronate | 74 | $679 | $9 |
| Tizanidine | 14 | $628 | $45 |
| Pantoprazole | 27 | $433 | $16 |
| Tramadol | 25 | $236 | $9 |
| Allopurinol | 33 | $197 | $6 |
| Omeprazole | 12 | $193 | $16 |
| Amlodipine Besylate | 28 | $189 | $7 |
| Insulin | 14 | $50 | $4 |
2013: 24 drugs
| Humira | 57 | $159,995 | $2,807 |
| Methotrexate | 251 | $16,342 | $65 |
| Lyrica | 22 | $6,216 | $283 |
| Celebrex | 24 | $5,606 | $234 |
| Hydroxychloroquine Sulfate | 222 | $4,285 | $19 |
| Actonel | 17 | $3,587 | $211 |
| Voltaren | 26 | $3,304 | $127 |
| Hydrocodone-Acetaminophen | 27 | $2,454 | $91 |
| Alendronate | 134 | $2,110 | $16 |
| Sulfasalazine | 69 | $2,000 | $29 |
| Sulfasalazine Dr | 37 | $1,974 | $53 |
| Gabapentin | 93 | $1,889 | $20 |
| Leflunomide | 35 | $1,402 | $40 |
| Prednisone | 107 | $1,292 | $12 |
| Leucovorin | 57 | $1,251 | $22 |
| Methotrexate | 11 | $837 | $76 |
| Pantoprazole | 28 | $382 | $14 |
| Omeprazole | 17 | $377 | $22 |
| Sulfazine | 11 | $317 | $29 |
| Tramadol | 18 | $160 | $9 |
| Allopurinol | 13 | $148 | $11 |
| Amlodipine Besylate | 29 | $147 | $5 |
| Insulin | 12 | $76 | $6 |
| Folic Acid | 13 | $51 | $4 |
Money from drug and device companies
$30 in 2025
| 2025 | 1 | 1 | None | $30 |
| 2024 | 1 | 1 | None | $17 |
| 2023 | 1 | 1 | None | $24 |
| 2020 | 1 | 2 | None | $30 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | Bimzelx | $30 | 1 payment
|
See the published payment
| Ucb | Meals · 2025-06-27 | Bimzelx | $30 |
See earlier years (2024, 2023, 2020)
2024: $17
| Abbvie | Rinvoq | $17 | 1 payment
|
2023: $24
| Exact Sciences | Cologuard Collection Kit | $24 | 1 payment
|
2020: $30
| Amgen | Otezla | $30 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1609987932
- Licence
- CA A67156California A67156: Current · expires 2028-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 227 N Jackson Ave, San Jose, CA, 95116
- NPI first listed
- 2006-08-31
- NPI last updated
- 2020-12-04
- NPI record certified
- 2020-12-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2585 Samaritan Dr, San Jose, CA, 95124